Trump Seeks to Lower Drug Prices Through Medicare and Some Imports

President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.

Trump’s Tariff Threat for Drug imports Poses Big Political Risks

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.

RFK Jr. Accuses FDA of Drug Industry Influence That Barred Alternative Remedies

The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address the mass layoffs that have gutted oversight of tobacco and vapes, food safety and drug reviews.

Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.

Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.

FDA Layoffs Could Raise Drug Costs and Erode Food Safety

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.

H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics

Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on preventing outbreaks of other pathogens.

Senators Press Marty Makary on Abortion Pills and Vaccines

At a hearing, Dr. Marty Makary, the nominee for F.D.A. commissioner, fielded questions focused on whether he would review or reopen certain policy areas.